用钠-葡萄糖协同转运蛋白2抑制剂治疗葡萄糖-6-磷酸酶催化亚基3缺乏患者的难治性伤口愈合和血细胞减少症。 - Suppr

Suppr

超能文献

Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency.

作者信息

Marois Louis, Le Gal Caridad, Cros Guilhem, Falcone Emilia Liana, Chapdelaine Hugo

机构信息

Department of Medicine, Université de Montréal, Montréal, Canada.

Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Canada.

出版信息

JAAD Case Rep. 2024 Apr 19;49:22-24. doi: 10.1016/j.jdcr.2024.04.011. eCollection 2024 Jul.

DOI:10.1016/j.jdcr.2024.04.011

PMID:38883182

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11179171/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8449/11179171/5d9fff0d840e/gr1.jpg

相似文献

Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency.用钠-葡萄糖协同转运蛋白2抑制剂治疗葡萄糖-6-磷酸酶催化亚基3缺乏患者的难治性伤口愈合和血细胞减少症。

JAAD Case Rep. 2024 Apr 19;49:22-24. doi: 10.1016/j.jdcr.2024.04.011. eCollection 2024 Jul.

Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.依帕列净成功治疗两例 G6PC3 缺陷患儿中性粒细胞减少症：SGLT5 突变的影响。

J Inherit Metab Dis. 2022 Jul;45(4):759-768. doi: 10.1002/jimd.12509. Epub 2022 May 24.

SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.SLGT2 抑制剂可挽救 G6PC3 缺乏症中的骨髓造血。

J Clin Immunol. 2022 Nov;42(8):1653-1659. doi: 10.1007/s10875-022-01323-4. Epub 2022 Jul 15.

Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.用 SGLT2 抑制剂治疗糖原贮积病 Ib 型的中性粒细胞减少症和中性粒细胞功能障碍。

Blood. 2020 Aug 27;136(9):1033-1043. doi: 10.1182/blood.2019004465.

DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia.DBS 适用于接受 SGLT2 抑制剂治疗中性粒细胞减少症的 GSD1b 和 G6PC3 缺陷患者进行 1,5-脱水葡萄糖醇监测。

Mol Genet Metab. 2023 Nov;140(3):107712. doi: 10.1016/j.ymgme.2023.107712. Epub 2023 Oct 24.

Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.未能消除磷酸化葡萄糖类似物会导致 G6PT 和 G6PC3 缺陷患者中性粒细胞减少。

Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1241-1250. doi: 10.1073/pnas.1816143116. Epub 2019 Jan 9.

Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia.人类葡萄糖-6-磷酸酶催化亚基 3 缺乏症的扩展谱：严重先天性中性粒细胞减少症中新型基因型和表型变异性。

J Pediatr. 2012 Apr;160(4):679-683.e2. doi: 10.1016/j.jpeds.2011.09.019. Epub 2011 Nov 1.

SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia.SGLT5 是 1,5-脱水葡萄糖醇的肾脏转运蛋白，而 1,5-脱水葡萄糖醇在两种罕见中性粒细胞减少症形式中扮演重要角色。

Cell Mol Life Sci. 2023 Aug 18;80(9):259. doi: 10.1007/s00018-023-04884-8.

Three patients with glucose-6 phosphatase catalytic subunit 3 deficiency.三例葡萄糖-6-磷酸酶催化亚基 3 缺乏症患者。

J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):957-961. doi: 10.1515/jpem-2019-0541.

A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.一名严重先天性中性粒细胞减少症患者中一种新的G6PC3基因突变。

J Pediatr Hematol Oncol. 2013 Mar;35(2):e81-3. doi: 10.1097/MPH.0b013e3182679000.

本文引用的文献

Treatment of the Neutropenia Associated with GSD1b and G6PC3 Deficiency with SGLT2 Inhibitors.用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂治疗与糖原贮积病1b型（GSD1b）和葡萄糖-6-磷酸酶催化亚基3（G6PC3）缺乏相关的中性粒细胞减少症。

Diagnostics (Basel). 2023 May 19;13(10):1803. doi: 10.3390/diagnostics13101803.

SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.SLGT2 抑制剂可挽救 G6PC3 缺乏症中的骨髓造血。

J Clin Immunol. 2022 Nov;42(8):1653-1659. doi: 10.1007/s10875-022-01323-4. Epub 2022 Jul 15.

J Inherit Metab Dis. 2022 Jul;45(4):759-768. doi: 10.1002/jimd.12509. Epub 2022 May 24.

Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib.恩格列净治疗糖原贮积病 Ib 型可改善炎症性肠病、伤口愈合和正常氧化爆发。

Orphanet J Rare Dis. 2020 Aug 24;15(1):218. doi: 10.1186/s13023-020-01503-8.

Blood. 2020 Aug 27;136(9):1033-1043. doi: 10.1182/blood.2019004465.

Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1241-1250. doi: 10.1073/pnas.1816143116. Epub 2019 Jan 9.

Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.葡萄糖-6-磷酸酶缺乏症 Ib 型中性粒细胞减少症：粒细胞集落刺激因子治疗患者的结局。

Curr Opin Hematol. 2019 Jan;26(1):16-21. doi: 10.1097/MOH.0000000000000474.

Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.长期使用粒细胞集落刺激因子与1b型糖原贮积病合并急性髓系白血病及端粒长度缩短有关。

Pediatr Hematol Oncol. 2018 Feb;35(1):45-51. doi: 10.1080/08880018.2018.1440675. Epub 2018 Apr 13.

Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry.来自法国严重先天性中性粒细胞减少症登记处的14例G6PC3基因突变患者的临床谱及长期随访

Orphanet J Rare Dis. 2014 Dec 10;9:183. doi: 10.1186/s13023-014-0183-8.

Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency.G6PC3 缺乏症中的炎症性肠病和 T 细胞减少症。

J Clin Immunol. 2013 Apr;33(3):520-5. doi: 10.1007/s10875-012-9833-6. Epub 2012 Nov 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验